WELL Health Technologies 将来の成長

Future 基準チェック /46

WELL Health Technologiesは、129.5%と14.3%でそれぞれ年率129.5%で利益と収益が成長すると予測される一方、EPSはgrowで129.9%年率。

主要情報

129.5%

収益成長率

129.87%

EPS成長率

Healthcare 収益成長	58.6%
収益成長率	14.3%
将来の株主資本利益率	n/a
アナリストカバレッジ	Good
最終更新日	05 Sep 2025

今後の成長に関する最新情報

WELL Health Technologies Corp. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Aug 16

Recent updates

WELL Health Technologies Corp. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Aug 16

Impressive Earnings May Not Tell The Whole Story For WELL Health Technologies (TSE:WELL)

Apr 23

Upgrade: Analysts Just Made A Captivating Increase To Their WELL Health Technologies Corp. (TSE:WELL) Forecasts

Apr 22

WELL Health Technologies Corp. (TSE:WELL) Might Not Be As Mispriced As It Looks After Plunging 28%

Apr 01

Are Investors Undervaluing WELL Health Technologies Corp. (TSE:WELL) By 45%?

Mar 29

AI-Driven Tools And Acquisitions Will Streamline Operations But Profit Margins May Decline

Jan 19 Market consolidation and clinic efficiency initiatives could significantly enhance WELL Health's revenue growth and net margins.

These 4 Measures Indicate That WELL Health Technologies (TSE:WELL) Is Using Debt Reasonably Well

Dec 31

A Piece Of The Puzzle Missing From WELL Health Technologies Corp.'s (TSE:WELL) 27% Share Price Climb

Nov 29

When Should You Buy WELL Health Technologies Corp. (TSE:WELL)?

Nov 11

Is WELL Health Technologies (TSE:WELL) A Risky Investment?

Sep 09

Market Participants Recognise WELL Health Technologies Corp.'s (TSE:WELL) Revenues Pushing Shares 30% Higher

Jul 05

WELL Health Technologies Corp.'s (TSE:WELL) Intrinsic Value Is Potentially 60% Above Its Share Price

Jun 11

業績と収益の成長予測

TSX:WELL - アナリストの将来予測と過去の財務データ ( )CAD Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2027	1,689	90	94	189	4
12/31/2026	1,566	16	96	153	14
12/31/2025	1,421	-17	86	86	14
6/30/2025	1,120	-116	45	83	N/A
3/31/2025	990	-25	-1	29	N/A
12/31/2024	920	33	-17	10	N/A
9/30/2024	934	61	33	47	N/A
6/30/2024	887	135	-12	10	N/A
3/31/2024	830	25	32	50	N/A
12/31/2023	776	0	41	66	N/A
9/30/2023	701	-7	60	81	N/A
6/30/2023	643	-4	61	76	N/A
3/31/2023	612	-5	67	81	N/A
12/31/2022	569	1	70	77	N/A
9/30/2022	528	-29	20	56	N/A
6/30/2022	482	-37	5	49	N/A
3/31/2022	403	-45	-19	34	N/A
12/31/2021	302	-44	-30	22	N/A
9/30/2021	204	-29	-13	10	N/A
6/30/2021	117	-21	-10	2	N/A
3/31/2021	66	-9	-4	-4	N/A
12/31/2020	50	-4	-7	-5	N/A
9/30/2020	43	-9	-5	-4	N/A
6/30/2020	39	-10	-4	-3	N/A
3/31/2020	36	-8	-4	-3	N/A
12/31/2019	33	-8	-3	-3	N/A
12/31/2018	9	-2	N/A	-1	N/A
10/31/2018	6	-2	N/A	-1	N/A
7/31/2018	4	-6	N/A	-1	N/A
4/30/2018	2	-6	N/A	-1	N/A
1/31/2018	0	-6	N/A	-1	N/A
10/31/2017	N/A	-1	N/A	-1	N/A
7/31/2017	0	-1	N/A	-1	N/A
3/31/2017	0	0	N/A	-1	N/A
12/31/2016	0	0	N/A	0	N/A
10/31/2016	0	-1	N/A	0	N/A
12/31/2015	0	-1	N/A	0	N/A

アナリストによる今後の成長予測

収入対貯蓄率: WELLは今後 3 年間で収益性が向上すると予測されており、これは貯蓄率 ( 2.6% ) よりも高い成長率であると考えられます。

収益対市場: WELL今後 3 年間で収益性が向上すると予想されており、これは市場平均を上回る成長と考えられます。

高成長収益: WELL今後 3 年以内に収益を上げることが予想されます。

収益対市場: WELLの収益 ( 14.3% ) Canadian市場 ( 4.1% ) よりも速いペースで成長すると予測されています。

高い収益成長: WELLの収益 ( 14.3% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: WELLの自己資本利益率が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です

成長企業の発掘

企業分析と財務データの現状

データ	最終更新日（UTC時間）
企業分析	2025/10/06 01:44
終値	2025/10/06 00:00
収益	2025/06/30
年間収益	2024/12/31

データソース

企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。

パッケージ	データ	タイムフレーム	米国ソース例
会社財務	10年	損益計算書キャッシュ・フロー計算書貸借対照表	SECフォーム10-K SECフォーム10-Q
アナリストのコンセンサス予想	+プラス3年	予想財務アナリストの目標株価	アナリストリサーチレポート Blue Matrix
市場価格	30年	株価配当、分割、措置	ICEマーケットデータ SECフォームS-1
所有権	10年	トップ株主インサイダー取引	SECフォーム4 SECフォーム13D
マネジメント	10年	リーダーシップ・チーム取締役会	SECフォーム10-K SECフォームDEF 14A
主な進展	10年	会社からのお知らせ	SECフォーム8-K

* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用^。

特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。

分析モデルとスノーフレーク

このレポートの作成に使用した分析モデルの詳細は、Githubページでご覧いただけます。また、レポートの使用方法に関するガイドや、Youtubeでのチュートリアルもご用意しています。

シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。

業界およびセクターの指標

私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。

アナリスト筋

WELL Health Technologies Corp. 14 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、。アナリストの投稿は一日中更新されます。15

アナリスト	機関
Gabriel Leung	Beacon Securities Limited
Douglas Taylor	Canaccord Genuity
Scott Fletcher	CIBC Capital Markets

WELL Health Technologies 将来の成長

Future 基準チェック /46

主要情報

今後の成長に関する最新情報

WELL Health Technologies Corp. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Well Health Technologies Corp. Reaffirms Earnings Guidance for 2025

WELL Health Technologies Corp. Updates Earnings Guidance for 2025

Consensus EPS estimates fall by 27%, revenue upgraded

Price target decreased by 8.9% to CA$7.65

Consensus revenue estimates increase by 15%

Recent updates

Insufficient new directors

WELL Health Technologies Corp. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Second quarter 2025 earnings: EPS exceeds analyst expectations

Well Health Technologies Corp. Reaffirms Earnings Guidance for 2025

WELL Health Technologies Corp. to Report Q2, 2025 Results on Aug 14, 2025

WELL Health Technologies Corp. Updates Earnings Guidance for 2025

WELL Health Technologies Corp. (TSX:WELL) acquired Specialty clinic in Burnaby, BC.

WELL Health Technologies Corp. Announces Appointment of Ric Leong as Chief Accounting Officer, Effective May 20

First quarter 2025 earnings: Revenues exceed analysts expectations while EPS lags behind

Consensus EPS estimates fall by 27%, revenue upgraded

WELL Health Technologies Corp. to Report Q1, 2025 Results on May 14, 2025

Price target decreased by 8.9% to CA$7.65

Impressive Earnings May Not Tell The Whole Story For WELL Health Technologies (TSE:WELL)

Upgrade: Analysts Just Made A Captivating Increase To Their WELL Health Technologies Corp. (TSE:WELL) Forecasts

Consensus revenue estimates increase by 15%

Full year 2024 earnings: EPS and revenues miss analyst expectations

WELL Health Technologies Corp. Provides Earnings Guidance for 2025

WELL Health Technologies Corp., Annual General Meeting, Jun 19, 2025

WELL Health Technologies Corp. to Report Q4, 2024 Results on Apr 14, 2025

WELL Health Technologies Corp. (TSE:WELL) Might Not Be As Mispriced As It Looks After Plunging 28%

Investor sentiment deteriorates as stock falls 21%

Are Investors Undervaluing WELL Health Technologies Corp. (TSE:WELL) By 45%?

WELL Health Technologies Corp. (TSX:WELL) completed the acquisition of Microquest Inc

Independent Director exercised options and sold CA$198k worth of stock

AI-Driven Tools And Acquisitions Will Streamline Operations But Profit Margins May Decline

These 4 Measures Indicate That WELL Health Technologies (TSE:WELL) Is Using Debt Reasonably Well

Price target increased by 8.9% to CA$8.37

Investor sentiment improves as stock rises 23%

WELL Health Technologies Corp. (TSX:WELL) completed the acquisition of Canadian Clinical Assets of Jack Nathan Health from Jack Nathan Medical Corp. (TSXV:JNH) for CAD 5 million.

A Piece Of The Puzzle Missing From WELL Health Technologies Corp.'s (TSE:WELL) 27% Share Price Climb

When Should You Buy WELL Health Technologies Corp. (TSE:WELL)?

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

WELL Health Technologies Corp. (TSX:WELL) entered into definitive agreement to acquire Canadian Clinical Assets of Jack Nathan Health from Jack Nathan Medical Corp. (TSXV:JNH) for CAD 5 million.

WELL Health Technologies Corp. to Report Q3, 2024 Results on Nov 07, 2024

Ms. CHAU Hoi Shuen Solina Holly acquired a 7.53% stake in WELL Health Technologies Corp. (TSX:WELL) for CAD 81.01 million.

Is WELL Health Technologies (TSE:WELL) A Risky Investment?

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

WELL Health Technologies Corp. Revised Revenue Guidance for the Year 2024

Consensus EPS estimates increase by 827%

Consensus EPS estimates fall by 13%

WELL Health Technologies Corp. to Report Q2, 2024 Results on Aug 14, 2024

Market Participants Recognise WELL Health Technologies Corp.'s (TSE:WELL) Revenues Pushing Shares 30% Higher

Chief Operating Officer exercised options to buy CA$1.6m worth of stock.

New major risk - Revenue and earnings growth

WELL Health Technologies Corp.'s (TSE:WELL) Intrinsic Value Is Potentially 60% Above Its Share Price

WELL Health Technologies' (TSE:WELL) Earnings Are Weaker Than They Seem

WELL Health Technologies Corp. Revises Revenue Guidance for the Year 2024

WELL Health Technologies Corp. to Report Q1, 2024 Results on May 08, 2024

WELL Health Technologies Corp., Annual General Meeting, Jun 12, 2024

Well Health Technologies Corp. Raises Earnings Guidance for 2024

Full year 2023 earnings released: EPS: CA$0 (vs CA$0.006 in FY 2022)

WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly

WELL Health Technologies Corp. to Report Q4, 2023 Results on Mar 21, 2024

Is WELL Health Technologies Corp. (TSE:WELL) Trading At A 40% Discount?

Independent Director exercised options and sold CA$144k worth of stock

WELL Health Technologies Corp. Announces the Creation of A Dedicated Public Sector Group to Help Tech Enable Public Health Systems Operating At Scale

Healwell AI Inc. (TSX:AIDX) completed the acquisition of Intrahealth Systems Limited from WELL Health Technologies Corp. (TSX:WELL) for approximately $24.2 million.

Healwell AI Inc. (TSX:AIDX) entered into an agreement to acquire Intrahealth Systems Limited from WELL Health Technologies Corp. (TSX:WELL) for approximately $24.2 million.

The Price Is Right For WELL Health Technologies Corp. (TSE:WELL)

WELL Health Technologies Corp. announced that it has received CAD 0.074876 million in funding

Well Health Announces Launch of Well Ai Inbox Admin: A Revolutionary Ai-Powered Solution for Clinic Inbox Management

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Well Health Technologies Corp. Provides Earnings Guidance for the Year 2023 and 2024

Consensus EPS estimates upgraded to CA$0.08 loss

WELL Health Technologies Corp. Launches WELL Longevity+ Program

WELL Health Technologies Corp. to Report Q3, 2023 Results on Nov 14, 2023

WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly

Independent Director recently sold CA$160k worth of stock

WELL Health Technologies Corp. (TSX:WELL) completed the acquisition of Clinic assets from MCI Medical Clinics Inc.